Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of tenofovir alafenamide as 10-day monotherapy in HIV-1-positive adults. [electronic resource]
Producer: 20130917Description: 449-55 p. digitalISSN:- 1944-7884
- Adenine -- adverse effects
- Adult
- Alanine
- Anti-Retroviral Agents -- pharmacokinetics
- Area Under Curve
- Dose-Response Relationship, Drug
- Fatigue -- chemically induced
- Female
- HIV Infections -- blood
- HIV-1
- Humans
- Male
- Middle Aged
- Nausea -- chemically induced
- Organophosphates -- blood
- Organophosphonates -- pharmacokinetics
- RNA, Viral -- blood
- Single-Blind Method
- Statistics, Nonparametric
- Tenofovir
- Viral Load
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.